The self-assembling peptide, our core technology, was discovered by Dr. Shuguang Zhang of the Massachusetts Institute of Technology (MIT) in the United States in 1992. The first-generation self-assembling peptide has been produced as PuraMatrix™. PuraMatrix™ consists of only amino acids existing in the body (16 residues) and forming microscopic structures (nanofibers) similar to natural extracellular matrix (ECM) under physiological conditions. The self-assembling peptide provides both the characteristics of safety as a chemically synthesized product, and the true three-dimensional environment created by ECM is a breakthrough material with multiple potential applications, making a contribution to the development of novel medical devices.